<VariationArchive RecordType="classified" VariationID="11128" VariationName="WAS, 15,800-BP DEL" VariationType="Deletion" Accession="VCV000011128" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-03" DateCreated="2018-01-19" MostRecentSubmission="2018-01-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26167" VariationID="11128">
      <GeneList>
        <Gene Symbol="WAS" FullName="WASP actin nucleation promoting factor" GeneID="7454" HGNC_ID="HGNC:12731" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48676636" stop="48691427" display_start="48676636" display_stop="48691427" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48542185" stop="48549817" display_start="48542185" display_stop="48549817" Strand="+" />
          </Location>
          <OMIM>300392</OMIM>
        </Gene>
      </GeneList>
      <Name>WAS, 15,800-BP DEL</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23-p11.22</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>15,800-BP DEL</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="300392.0015" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff could not provide an HGVS expression for allelic variant 300392.0015 because the upstream sequence reported in Figure 3c (AF466616.1) of the paper by Lutskiy et al., 2002 (PubMed 12073025) is not included in the reference assembly. If an HGVS expression were constructed from the description of the deletion starting 12997 bp upstream of the start codon, and extending to the downstream sequence in the figure, the HGVS expression would be NC_000023.11:g.48670857_48686646delinsCAGGG.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="WAS, 15,800-BP DEL AND Wiskott-Aldrich syndrome" Accession="RCV000011877" Version="19">
        <ClassifiedConditionList TraitSetID="3075">
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2002-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-01-19" MostRecentSubmission="2018-01-19">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12073025</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3075" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32110" SubmissionDate="2018-01-16" DateLastUpdated="2018-01-19" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300392.0015_WISKOTT-ALDRICH SYNDROME" title="WAS, 15,800-BP DEL_WISKOTT-ALDRICH SYNDROME" />
        <ClinVarAccession Accession="SCV000032110" DateUpdated="2018-01-19" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Lutskiy et al. (2002) described a patient with Wiskott-Aldrich syndrome (WAS; 301000) with a large deletion in the Xp11.23 region. The deletion, which totaled 15.8 kb, began downstream of DXS1696 and encompassed 13 kb upstream of WASP and included the distal and proximal promoters and exons 1 through 6. The upstream breakpoint was localized in an Alu element. A 26-bp recombinogenic element was located downstream of the 5-prime breakpoint. A 16-bp sequence just upstream of the 5-prime breakpoint shared close homology with the sequence that spanned the 3-prime breakpoint in intron 6. A heptanucleotide of unknown origin, CAGGGGG, linked the 5-prime and 3-prime breakpoints. Lutskiy et al. (2002) stated that this was the largest deletion identified in a Wiskott-Aldrich syndrome patient. The diagnosis had been made at the age of 3 months when he presented with thrombocytopenia, small platelets, severe eczema, bloody diarrhea, and recurrent otitis media. He received regular immunoglobulin transfusions; at age 2 years, splenectomy was performed and, at age 4, he received a bone marrow transplant from an HLA-matched unrelated donor.</Attribute>
              <Citation>
                <ID Source="PubMed">12073025</ID>
              </Citation>
              <XRef DB="OMIM" ID="301000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <Name>WAS, 15,800-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">15,800-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300392.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WISKOTT-ALDRICH SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32110" TraitType="Disease" MappingType="Name" MappingValue="WISKOTT-ALDRICH SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

